DK219084D0 - Antigen - Google Patents
AntigenInfo
- Publication number
- DK219084D0 DK219084D0 DK2190/84A DK219084A DK219084D0 DK 219084 D0 DK219084 D0 DK 219084D0 DK 2190/84 A DK2190/84 A DK 2190/84A DK 219084 A DK219084 A DK 219084A DK 219084 D0 DK219084 D0 DK 219084D0
- Authority
- DK
- Denmark
- Prior art keywords
- antigen
- adhesin
- determinant
- antibodies against
- immunogenically active
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 4
- 108091007433 antigens Proteins 0.000 title abstract 4
- 102000036639 antigens Human genes 0.000 title abstract 4
- 108010037896 heparin-binding hemagglutinin Proteins 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/82—Subcellular parts of microorganisms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK2190/84A DK219084D0 (da) | 1984-05-02 | 1984-05-02 | Antigen |
US06/817,849 US4795803A (en) | 1984-05-02 | 1985-05-02 | Adhesin antigens, antibodies and DNA fragment encoding the antigen, methods and means for diagnosis and immunization etc. |
IE110285A IE59826B1 (en) | 1984-05-02 | 1985-05-02 | Adhesin antigens, antibodies and dna fragment encoding the entigen, methods and means for diagnosis and immunization etc. |
KR1019850700417A KR950000688B1 (ko) | 1984-05-02 | 1985-05-02 | 어드히진(Adhesin) 항원의 제조방법 및 그 항원에서 유도되는 항체의 제조방법 |
PCT/DK1985/000045 WO1985005037A1 (en) | 1984-05-02 | 1985-05-02 | Adhesin antigens, antibodies and dna fragment encoding the antigen, methods and means for diagnosis and immunization etc. |
JP60502188A JP2974028B2 (ja) | 1984-05-02 | 1985-05-02 | アドヒシン抗原類 |
EP85902487A EP0179887B1 (en) | 1984-05-02 | 1985-05-02 | Adhesin antigens, antibodies and dna fragment encoding the antigen, methods and means for diagnosis and immunization etc. |
AU42994/85A AU593770B2 (en) | 1984-05-02 | 1985-05-02 | Adhesin antigens, antibodies and DNA fragment encoding the antigen, methods and means for diagnosis and immunization etc |
AT85902487T ATE91629T1 (de) | 1984-05-02 | 1985-05-02 | Adhesin-antigene, antikoerper und dns-fragmente die das antigen kodieren, verfahren und mittel zur diagnose und immunisierung, usw. |
DE85902487T DE3587468T2 (de) | 1984-05-02 | 1985-05-02 | Adhesin-antigene, antikörper und dns-fragmente die das antigen kodieren, verfahren und mittel zur diagnose und immunisierung, usw. |
CA000480663A CA1340847C (en) | 1984-02-02 | 1985-05-02 | Adhesin antigens |
DK609985A DK171258B1 (da) | 1984-05-02 | 1985-12-30 | Antigent præparat indeholdende en determinant fra et adhesin-polypeptid, fremgangsmåder til fremstilling af deteminanten og adhesin-polypeptidet, anvendelser af determinanten og adhesin-polypeptidet, vaccine indeholdende determinanten, fremgangsmåde til fremstilling af vaccinen, antistof rettet mod determinanten, fremgangsmåde til fremstilling af antistoffet, præparatet til passiv immunisering |
SU864001551A RU1787165C (ru) | 1984-05-02 | 1986-01-02 | Способ получени антигенного препарата, обладающего адгезивными свойствами, из фимбрий |
FI860015A FI93310C (fi) | 1984-05-02 | 1986-01-02 | Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan |
US08/447,685 US5804198A (en) | 1984-05-02 | 1995-05-23 | Vaccines against disease caused by pathogenic pilus-forming bacteria |
JP8162018A JPH09183791A (ja) | 1984-05-02 | 1996-06-21 | Dna断片 |
US09/075,396 US6291649B1 (en) | 1984-05-02 | 1998-05-11 | Anti-bodies binding adhesin-derived antigens |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK2190/84A DK219084D0 (da) | 1984-05-02 | 1984-05-02 | Antigen |
Publications (1)
Publication Number | Publication Date |
---|---|
DK219084D0 true DK219084D0 (da) | 1984-05-02 |
Family
ID=8110676
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK2190/84A DK219084D0 (da) | 1984-02-02 | 1984-05-02 | Antigen |
DK609985A DK171258B1 (da) | 1984-05-02 | 1985-12-30 | Antigent præparat indeholdende en determinant fra et adhesin-polypeptid, fremgangsmåder til fremstilling af deteminanten og adhesin-polypeptidet, anvendelser af determinanten og adhesin-polypeptidet, vaccine indeholdende determinanten, fremgangsmåde til fremstilling af vaccinen, antistof rettet mod determinanten, fremgangsmåde til fremstilling af antistoffet, præparatet til passiv immunisering |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK609985A DK171258B1 (da) | 1984-05-02 | 1985-12-30 | Antigent præparat indeholdende en determinant fra et adhesin-polypeptid, fremgangsmåder til fremstilling af deteminanten og adhesin-polypeptidet, anvendelser af determinanten og adhesin-polypeptidet, vaccine indeholdende determinanten, fremgangsmåde til fremstilling af vaccinen, antistof rettet mod determinanten, fremgangsmåde til fremstilling af antistoffet, præparatet til passiv immunisering |
Country Status (13)
Country | Link |
---|---|
US (3) | US4795803A (ja) |
EP (1) | EP0179887B1 (ja) |
JP (2) | JP2974028B2 (ja) |
KR (1) | KR950000688B1 (ja) |
AT (1) | ATE91629T1 (ja) |
AU (1) | AU593770B2 (ja) |
CA (1) | CA1340847C (ja) |
DE (1) | DE3587468T2 (ja) |
DK (2) | DK219084D0 (ja) |
FI (1) | FI93310C (ja) |
IE (1) | IE59826B1 (ja) |
RU (1) | RU1787165C (ja) |
WO (1) | WO1985005037A1 (ja) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4736017A (en) * | 1984-04-30 | 1988-04-05 | The Board Of Trustees Of The Leland Stanford Junior University | Chemically defined vaccine against urinary infections |
US4584195A (en) * | 1984-06-21 | 1986-04-22 | The Board Of Trustees Of The Leland Stanford Junior University | Broad spectrum vaccine against gonorrhea |
US4740585A (en) * | 1984-07-30 | 1988-04-26 | The Board Of Trustees Of The Leland Stanford Junior University | Synthetic vaccine against urinary infections |
US5288617A (en) * | 1984-10-31 | 1994-02-22 | Commonwealth Scientific And Industrial Research Organization | Method of producing an antigenic preparation |
EP0202260B1 (en) * | 1984-10-31 | 1992-06-03 | Commonwealth Scientific And Industrial Research Organisation | Improved antigenic preparation |
IL78775A (en) * | 1985-05-15 | 1992-06-21 | Biotech Australia Pty Ltd | Oral vaccines |
EP0211352B1 (en) * | 1985-08-01 | 1994-03-16 | Miles Inc. | Protective antibodies to serotypic determinants of flagellar antigens |
US4900659A (en) * | 1986-01-30 | 1990-02-13 | Enzo Biochem, Inc. | Nucleotide sequence composition and method for detection of Neisseria gonorrhoeae and method for screening for a nucleotide sequence that is specific for a genetically distinct group |
US4801690A (en) * | 1986-03-24 | 1989-01-31 | Bactex, Inc. | Novel lectins derived from bacterial pili |
SE8601940D0 (sv) * | 1986-04-25 | 1986-04-25 | Kabigen Ab | Preparation of fused proteins, antibodies and processes therefor |
US4786592A (en) * | 1986-06-18 | 1988-11-22 | Scripps Clinic And Research Foundation | Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin |
US7087742B1 (en) | 1986-11-24 | 2006-08-08 | Gen-Probe Incorporated | Oligonucleotide probes for the detection and/or quantitation of non-viral organisms |
US7138516B1 (en) | 1986-11-24 | 2006-11-21 | Gen-Probe Incorporated | Oligonucleotide probes for the detection and/or quantitation of non-viral organisms |
US5036003A (en) * | 1987-08-21 | 1991-07-30 | Monsanto Company | Antibodies to VPF |
AU601510B2 (en) * | 1987-11-06 | 1990-09-13 | Immunomed Corporation | Preparation of bacterium pili subunits and vaccines containing pili subunits |
SE8801894D0 (sv) * | 1988-05-20 | 1988-05-20 | Alfa Laval Agri Int | Fibronektinbindande protein |
US5055455A (en) | 1988-09-28 | 1991-10-08 | Brigham And Women's Hospital | Capsular polysaccharide adhesin antigen, preparation, purification and use |
US7172863B1 (en) | 1988-12-09 | 2007-02-06 | Gen-Probe Incorporated | Nucleic acid probes and methods for detecting Neisseria gonorrhoeae |
CA1340530C (en) * | 1989-04-28 | 1999-05-04 | Kok Kheong Lee | Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics |
SE8901687D0 (sv) * | 1989-05-11 | 1989-05-11 | Alfa Laval Agri Int | Fibronectin binding protein as well as its preparation |
US5202113A (en) * | 1990-04-30 | 1993-04-13 | The United States Of America As Represented By The Department Of Health And Human Services | Plaque-inhibiting protein from bacteroides loeschei and methods for using the same |
CA2095642C (en) * | 1990-08-02 | 1999-12-14 | Howard C. Krivan | Adhesion receptors for pathogenic or opportunistic microorganisms |
US5440014A (en) * | 1990-08-10 | 1995-08-08 | H+E,Uml/Oo/ K; Magnus | Fibronectin binding peptide |
US5843463A (en) * | 1990-12-21 | 1998-12-01 | Antexbiologics, Inc. | Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae |
WO1992011367A2 (en) * | 1990-12-21 | 1992-07-09 | Microcarb Inc. | Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof |
US5834591A (en) * | 1991-01-31 | 1998-11-10 | Washington University | Polypeptides and antibodies useful for the diagnosis and treatment of pathogenic neisseria and other microorganisms having type 4 pilin |
US5980908A (en) * | 1991-12-05 | 1999-11-09 | Alfa Laval Ab | Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment |
AU662783B2 (en) * | 1992-01-08 | 1995-09-14 | De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur | Whooping cough vaccine |
DE69431624T2 (de) * | 1993-05-18 | 2003-07-10 | The Ohio State University Research Foundation, Columbus | Impfstoff gegen mittelohrentzündung |
US5648240A (en) * | 1994-05-24 | 1997-07-15 | Texas A&M University | MHC II analog from Staphylococcus aureus |
AU2816095A (en) * | 1994-06-24 | 1996-01-19 | Children's Hospital Medical Center | Escherichia coli o157:h7 epithelial adhesin |
DE19534579C2 (de) * | 1995-09-18 | 2000-06-08 | Max Planck Gesellschaft | Nucleinsäure-Moleküle codierend Proteine, die die Adhäsion von Neisseria-Zellen an humane Zellen vermitteln |
US6872398B2 (en) * | 1995-12-22 | 2005-03-29 | The United States Of America As Represented By The Secretary Of The Army | Conjugate vaccine against gram-negative bacterial infections |
NZ333250A (en) * | 1996-06-10 | 2000-05-26 | Thomas Boren | Helicobacter pylori blood group antigen binding adhesion protein |
WO1999036544A2 (en) * | 1998-01-14 | 1999-07-22 | Chiron S.P.A. | Neisseria meningitidis antigens |
US7252828B2 (en) | 1998-07-15 | 2007-08-07 | The Brigham And Women's Hospital, Inc. | Polysaccharide vaccine for staphylococcal infections |
CA2341177A1 (en) * | 1998-08-31 | 2000-03-09 | Inhibitex, Inc. | Staphylococcal immunotherapeutics via donor selection and donor stimulation |
US6692739B1 (en) | 1998-08-31 | 2004-02-17 | Inhibitex, Inc. | Staphylococcal immunotherapeutics via donor selection and donor stimulation |
US20040001863A1 (en) * | 1998-12-03 | 2004-01-01 | Shau-Chi Chi | Immortal cell line derived from grouper Epinephelus coioides and its applications therein |
GB9924351D0 (en) | 1999-10-14 | 1999-12-15 | Brennan Frank | Immunomodulation methods and compositions |
AU784557B2 (en) * | 1999-12-21 | 2006-05-04 | Merial | Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen |
EP1328543B1 (en) * | 2000-10-27 | 2009-08-12 | Novartis Vaccines and Diagnostics S.r.l. | Nucleic acids and proteins from streptococcus groups a & b |
KR20030071861A (ko) | 2001-01-26 | 2003-09-06 | 인히비텍스, 인코포레이티드 | Clfa 단백질에 대한 단일 클론성 항체 및 감염의 치료또는 예방에 있어서의 사용 방법 |
US7396822B2 (en) | 2001-05-24 | 2008-07-08 | Vaxiion Therapeutics, Inc. | Immunogenic minicells and methods of use |
US20030194798A1 (en) | 2001-05-24 | 2003-10-16 | Surber Mark W. | Minicell compositions and methods |
US7132101B2 (en) * | 2002-02-27 | 2006-11-07 | Duquesne University Of The Holy Ghost | Compositions and methods for eliciting an immune response to gram-negative bacterial infections |
AU2003256329A1 (en) * | 2002-06-27 | 2004-01-19 | University Of Washington | Use of adhesion molecules as bond stress-enhanced nanoscale binding switches |
ES2648046T3 (es) | 2002-11-12 | 2017-12-28 | The Brigham And Women's Hospital, Inc. | Vacuna de polisacárido para infecciones estafilocócicas |
AU2003290867A1 (en) * | 2002-11-12 | 2004-06-03 | The Brigham And Women's Hospital, Inc. | Methods and products for treating staphylococcal infections |
WO2006055024A2 (en) * | 2004-04-05 | 2006-05-26 | Vaxiion Therapeutics, Inc. | Minicells as vaccines |
EP2455401B1 (en) * | 2004-04-21 | 2018-01-24 | The Brigham and Women's Hospital, Inc. | Poly-n-acetyl glucosamine (pnag/dpnag)-binding antibodies |
US8251846B2 (en) * | 2006-08-02 | 2012-08-28 | Wilson Sporting Goods Co. | Game ball having optimally positioned grooves |
US7585236B2 (en) * | 2006-08-02 | 2009-09-08 | Wilson Sporting Goods Co. | Game ball having optimally positioned grooves and/or ridges |
US7686713B2 (en) * | 2007-04-11 | 2010-03-30 | Wilson Sporting Goods Co. | Racquet stringing machine |
EP2139993A2 (en) * | 2007-04-27 | 2010-01-06 | Dow Global Technologies Inc. | Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
CN105085349B (zh) * | 2008-07-21 | 2018-02-09 | 布赖汉姆妇女医院 | 与合成的β‑1,6 葡糖胺寡糖相关的方法和组合物 |
WO2012112696A1 (en) | 2011-02-15 | 2012-08-23 | Vaxiion Therapeutics, Inc. | Therapeutic compositions and methods for antibody and fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1332108B (en) | 1908-12-21 | 1909-11-30 | Improvements in means for transporting merchandise and other material in connection with the loading and unloading of vehicles | |
AU853813B (en) | 1913-03-31 | 1914-04-11 | George Reid Angus | Improvements in the manufacture of filter frames for beer and other liquids |
GB1472624A (en) * | 1974-09-02 | 1977-05-04 | Canadian Patents Dev | Enteric disease vaccine |
US4461838A (en) * | 1975-04-25 | 1984-07-24 | Bactex, Inc. | Gonococcal Pili processes for the preparation thereof and the use thereof for the detection of and prevention of infections caused by Neisseria gonorrhoeae |
NL7604311A (nl) * | 1975-04-25 | 1976-10-27 | Bactex Inc | Werkwijze voor het isoleren van pilus kristal- len uit n-gonorrhoeae en werkwijzen voor het toepassen van de zo verkregen kristallen. |
GB1553664A (en) * | 1975-06-12 | 1979-09-26 | Unilever Ltd | Antigenic compositions |
US4136167A (en) * | 1975-06-12 | 1979-01-23 | Internationale Octrooi Maatschappij "Octropa" B.V. | Process for reducing the incidence of neonatal diarrhoea in pigs |
US4237115A (en) * | 1977-11-23 | 1980-12-02 | Bactex, Inc. | Method of immunization against enterotoxogenic infection by Escherichia coli |
US4336336A (en) * | 1979-01-12 | 1982-06-22 | President And Fellows Of Harvard College | Fused gene and method of making and using same |
FR2466251B1 (fr) * | 1979-10-03 | 1983-03-18 | Agronomique Inst Nat Rech | Vaccin animal anticolibacillaire, obtention et application |
US4311797A (en) * | 1979-09-18 | 1982-01-19 | University Of Saskatchewan | Anucleated live E. coli vaccine |
SE8001748L (sv) * | 1980-03-05 | 1981-09-06 | Kaellenius Gunilla | Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik |
US4454117A (en) * | 1980-09-15 | 1984-06-12 | Bactex, Inc. | Immunization against infection by Escherichia coli |
GB2094314A (en) * | 1981-02-05 | 1982-09-15 | Wellcome Found | Recombinant DNA |
WO1982003088A1 (en) * | 1981-03-09 | 1982-09-16 | Corp Cetus | Vaccines |
US4443431A (en) * | 1981-05-27 | 1984-04-17 | The United States Of America As Represented By The Department Of Health And Human Services | Neisseria gonorrhoeae vaccine |
US4443549A (en) * | 1981-10-19 | 1984-04-17 | Molecular Genetics, Inc. | Production of monoclonal antibodies against bacterial adhesins |
DK462182A (da) * | 1981-10-19 | 1983-04-20 | Molecular Genetics Inc | Fremgangsmaade til fremstilling af antiadhaesin-antistoffer og antipilus-antistoffer samt kontinuerlig cellelinie til brug herved |
FR2516385A1 (fr) * | 1981-11-19 | 1983-05-20 | Merieux Inst | Vaccin anti-aphteux et anti-colibacillaire et son procede de preparation |
WO1983002456A2 (en) * | 1982-01-18 | 1983-07-21 | Ceska, Miroslav | New plasmids and bacterial strains and production process thereo f |
EP0089940A1 (en) * | 1982-03-23 | 1983-09-28 | BioCarp AB | Compositions for therapeutic or diagnostic use containing oligosaccharides |
US4597967A (en) * | 1982-07-27 | 1986-07-01 | The University Of Tennessee Research Corp. | Synthetic polypeptide fragments |
US4521334A (en) * | 1982-07-27 | 1985-06-04 | The University Of Tennesse Research Corporation | Synthetic polypeptide fragments |
NZ205392A (en) * | 1982-09-02 | 1987-03-06 | Unilever Plc | Preparation of immunoglobulins against e.coli pili |
US4652448A (en) * | 1982-10-07 | 1987-03-24 | Molecular Genetics, Inc. | Use of monoclonal antibodies against bacterial adhesins |
US4736017A (en) * | 1984-04-30 | 1988-04-05 | The Board Of Trustees Of The Leland Stanford Junior University | Chemically defined vaccine against urinary infections |
US4801690A (en) * | 1986-03-24 | 1989-01-31 | Bactex, Inc. | Novel lectins derived from bacterial pili |
US4786592A (en) * | 1986-06-18 | 1988-11-22 | Scripps Clinic And Research Foundation | Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin |
-
1984
- 1984-05-02 DK DK2190/84A patent/DK219084D0/da not_active Application Discontinuation
-
1985
- 1985-05-02 CA CA000480663A patent/CA1340847C/en not_active Expired - Fee Related
- 1985-05-02 KR KR1019850700417A patent/KR950000688B1/ko not_active IP Right Cessation
- 1985-05-02 IE IE110285A patent/IE59826B1/en not_active IP Right Cessation
- 1985-05-02 WO PCT/DK1985/000045 patent/WO1985005037A1/en active IP Right Grant
- 1985-05-02 JP JP60502188A patent/JP2974028B2/ja not_active Expired - Lifetime
- 1985-05-02 DE DE85902487T patent/DE3587468T2/de not_active Expired - Lifetime
- 1985-05-02 US US06/817,849 patent/US4795803A/en not_active Expired - Lifetime
- 1985-05-02 AU AU42994/85A patent/AU593770B2/en not_active Expired
- 1985-05-02 EP EP85902487A patent/EP0179887B1/en not_active Expired - Lifetime
- 1985-05-02 AT AT85902487T patent/ATE91629T1/de not_active IP Right Cessation
- 1985-12-30 DK DK609985A patent/DK171258B1/da not_active IP Right Cessation
-
1986
- 1986-01-02 RU SU864001551A patent/RU1787165C/ru active
- 1986-01-02 FI FI860015A patent/FI93310C/fi not_active IP Right Cessation
-
1995
- 1995-05-23 US US08/447,685 patent/US5804198A/en not_active Expired - Fee Related
-
1996
- 1996-06-21 JP JP8162018A patent/JPH09183791A/ja active Pending
-
1998
- 1998-05-11 US US09/075,396 patent/US6291649B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK171258B1 (da) | 1996-08-12 |
FI93310C (fi) | 1995-03-27 |
DE3587468T2 (de) | 1993-12-02 |
EP0179887A1 (en) | 1986-05-07 |
FI860015A (fi) | 1986-01-02 |
DK609985D0 (da) | 1985-12-30 |
JPS62501355A (ja) | 1987-06-04 |
KR950000688B1 (ko) | 1995-01-27 |
AU593770B2 (en) | 1990-02-22 |
ATE91629T1 (de) | 1993-08-15 |
US5804198A (en) | 1998-09-08 |
EP0179887B1 (en) | 1993-07-21 |
DE3587468D1 (de) | 1993-08-26 |
JP2974028B2 (ja) | 1999-11-08 |
US6291649B1 (en) | 2001-09-18 |
FI93310B (fi) | 1994-12-15 |
RU1787165C (ru) | 1993-01-07 |
WO1985005037A1 (en) | 1985-11-21 |
AU4299485A (en) | 1985-11-28 |
CA1340847C (en) | 1999-12-14 |
FI860015A0 (fi) | 1986-01-02 |
US4795803A (en) | 1989-01-03 |
JPH09183791A (ja) | 1997-07-15 |
IE851102L (en) | 1985-11-02 |
KR860700090A (ko) | 1986-03-31 |
DK609985A (da) | 1985-12-30 |
IE59826B1 (en) | 1994-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK219084D0 (da) | Antigen | |
ATE117370T1 (de) | Chimärer antikörper mit spezifität für menschliches tumor-antigen. | |
DK0626447T3 (da) | Monoklonale antistoffer og Fv, som er specifikke for CD2-antigen | |
PT86792A (pt) | Monoclonal antibodies against melanoma-associated antigens hybrid cell lines producing these antibodies and use therefor | |
EP0434713A4 (en) | Hiv-1 envelope muteins lacking hypervariable domains | |
ATE7855T1 (de) | Herstellung von virusantigenen. | |
ES8504255A1 (es) | Procedimiento para la produccion de una hormona de crecimiento de porcino. | |
ATE103989T1 (de) | Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung. | |
KR950018454A (ko) | 단백질 c를 생성시키는 방법 | |
KR890003944A (ko) | 인간/인간 하이브리도마 배양용 무혈청배지 | |
DE3580524D1 (de) | Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen. | |
KR890016165A (ko) | 수도모나스 아에루기노사(Pseudomonas aeruginosa)에 대한 모노클로날 항체, 이의 제조방법 및 용도 | |
KR890002402A (ko) | 인간의 유두종바이러스형 41, 이의 dna 및 이로부터 코드화된 단백질 | |
ATE56617T1 (de) | Anti-urokinase monoklonaler antikoerper, seine herstellung und verwendung. | |
AU7144787A (en) | Tumor-associated antigen (mol wt 68,000-48000; 40,000-80000; 28000-32000; 16000-19000) | |
ES2038601T3 (es) | Procedimiento para preparar 4-androsten-3,17-diona y 1,4-androstadien-3,17-diona. | |
KR870006190A (ko) | 생리 활성 물질의 제조방법 | |
KR950031110A (ko) | 인간 혈증 아포지단백질 비-100(b-100)에 대한 신규 단일클론 항체 및 이들의 생산을 위한 재조합 하이브리도마 세포주 | |
KR960006941A (ko) | 인간 혈중 아포지단백질(apolipoprotein) A-I에 대한 신규 단일클론 항체 및 이들의 생산을 위한 재조합 하이브리도마 세포주 | |
KR880001825A (ko) | 발효에 의한 5'-구아닐산의 제조방법 | |
JPS6439992A (en) | Monoclonal antibody |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHS | Application shelved for other reasons than non-payment |